George v. Commissioner: How Retroactive R&D Tax Credit Documentation Failed Under Audit

In today’s hyper-scrutinized tax environment, simply doing legitimate research and development is not enough to be able to claim R&D tax credits. A company must be able to prove it did legitimate research and development. Often, companies build the case for R&D tax credits retroactively, using a combination of existing data and employee interviews as proof for the work. But the case of George v. Commissioner shows what can go very wrong with this approach.

George’s of Missouri, Inc. (GOMI) — one of the largest fully integrated poultry processors in the U.S. — claimed $4.47 million in R&D tax credits across 2012–2014 for seven research trials on feed additives,vaccines, probiotics, and genetic lines. alliantgroup conducted the retroactive R&D study.
The Tax Court’s verdict was a blow. They disallowed three of seven trials, and the credit rate was slashed from 14% to 6%. Not because the research wasn’t real — but because the documentation couldn’t prove it.

GOMI’s research was legitimate — trials on Ross 708 genetic lines, probiotic additives like Sporulin and Calsporin, and vaccine protocols were real scientific work conducted by qualified personnel. But the R&D study was built retroactively by alliant group, relying on employee interviews conducted months or years after the research occurred. When the IRS compared those interviews narratives against GOMI’s own operational records — feed logs, flock data, procurement records — the contradictions were fatal.

The court found that feed records showed constant, unchanged dosages during periods where consultants claimed active experimentation was occurring. Entire flocks that allegedly received test additives had no documentation whatsoever. And credits were claimed for research years after the underlying uncertainty had already been resolved.

On top of the individual trial failures, GOMI couldn’t substantiate its base-year qualified research expenses, triggering a start-up limitation under IRC §41(c)(5)(B) that cut the credit rate from 14% to just6% — compounding the losses across every surviving claim.

The root cause of every failure in George v. Commissioner was not the legitimacy of the research itself – it was the retroactive documentation approach that made it impossible to substantiate. Here is a breakdown of exactly where the documentation failed.

The R&D Tax Credit Documentation Failures That Cost Millions

Of seven research trials, three were completely disallowed and two were only partially allowed. Every failure traced to the same root cause: retroactive documentation that contradicted operational records.

1. Disallowed and Partially Allowed R&D Tax Credit Claims

• Salinomycin & Phytase — Interview claims of experimentation contradicted by feed records showing constant, unchanged dosages (~$1.2M in QREs at risk)
• Floramax — No records existed showing which flocks received the additive; the court refused to estimate (~$680K in QREs unsubstantiated)
• HatchPak & Tylan — Credit claimed for 2013 after uncertainty was already resolved in 2012 ($2.87M credit year partially disallowed)
• LT Vaccines — Priming trials allowed, but method-of-administration lacked timing records (partial credit reduction)

Combined with the base-year failure cutting the rate from 14% to 6%, the total credit impact was devastating across all $4.47M claimed

2. Allowed Claims: The Documentation Standard That Won

• Ross 708 Genetic Line — Called “the cleanest example of the scientific method” — control groups, data analysis, clear conclusions
• Sporulin & Calsporin — Clear hypothesis, test, analyze, iterate pattern with documented next steps upon failure

These trials survived because their documentation matched what Exactera captures automatically for every project

The Base-Year Penalty

Beyond individual trial failures, GOMI couldn’t substantiate base-year QREs (2009–2011). This triggered the start-up limitation under §41(c)(5)(B), slashing the credit rate from 14% to 6% — losing more than half the credit value on every qualifying trial. Exactera’s platform maintains rolling base-year data automatically, making this trap structurally impossible.

But the base-year penalty is just one symptom of a deeper structural problem, and it is one that affects far more companies than just GOMI. The retroactive study model itself is the root cause.

Why This Keeps Happening: The Structural Flaws of the Retroactive R&D Documentation Model

The failures in George aren’t unique — they’re structural. alliantgroup and traditional R&D firms all use the same retroactive model:

1. Research happens. No credit-specific documentation is captured.

2. 6–18 months later, consultants arrive and interview employees from memory.

3. Narratives are manually reconstructed — often contradicted by operational records the consultants never reviewed.

4. A static report is delivered. When the IRS finds discrepancies, there’s no way to fix them.

This is the model that produced three disallowed trials and a credit rate cut in half. The new Form 6765 makes this approach even riskier by requiring project-level detail and contemporaneous evidence that retroactive studies were never designed to produce.

The question is no longer whether retroactive R&D documentation carries risk – George v. Commissioner answered that definitively. The question is what a contemporaneous, audit-ready approach to R&D tax credit documentation actually looks like in practice.

Traditional Documentation Methods vs. Exactera’s Approach

1. DIY / IN-HOUSE

• No formal documentation process: Engineers focus on research, not tax compliance — critical evidence is never captured
• No QRE methodology: No understanding of what qualifies; expenses lumped together or guessed at filing time
• Static point-in-time report: Can’t be updated or verified against live data
• No four-part test awareness: Activities claimed without mapping to §174, business component, or experimentation tests
• No base-year tracking: Historical QRE data doesn’t exist; start-up limitation almost guaranteed
• Maximum audit exposure: No defensible position — IRS can disallow the entire credit with minimal disruption

The DIY approach leaves companies entirely exposed, but the traditional retroactive study model used by most R&D tax credit firms carries its own distinct set of structural risks, as George v. Commissioner made clear.

2. RETROACTIVE R&D CREDIT STUDY

• Interview-based narratives: Written from fading memories months after research ends
• Manual QRE allocation: Spreadsheet estimates with no audit trail
• Four-Part Test Applied Retrospectively, Not Validated During Research: Qualification assessed retrospectively. Four-part test applied by consultants, not validated during research
• Base-year records not maintained: Left to the client — often lost or incomplete
• Partial, fragile defense: Retroactive narratives collapse when compared to operational records

The contemporaneous, project-level documentation standard that survived IRS scrutiny in George v. Commissioner is not achieved through retroactive studies – it is what Exactera’s real-time AI approach is built to capture automatically.

3. EXACTERA’S REAL-TIME AI

• Live documentation capture: Project data ingested as research happens — no recall required
• Automated QRE engine: Wages, supplies, and contracts tied to projects from payroll and GL data
• Living, audit-ready output: Continuously updated documentation that maps to Form 6765 sections
• AI-powered qualification: Four-part test evaluated continuously — issues flagged before filing
• Rolling base-year maintenance: Platform tracks base-period QREs automatically from year one
• Minimized audit risk: Contemporaneous, system-generated evidence designed to withstand IRS scrutiny

New Form 6765 Compliance: Three Approaches Compared

1. Contemporaneous documentation

• DIY / In-House: Non-existent
• Retroactive Study: Structurally impossible
• Exactera AI: Core architecture

2. Project-level narratives

• DIY / In-House: Not attempted
• Retroactive Study: Interview recall; contradiction risk
• Exactera AI: Auto-generated from live data

3. QRE allocation by project

• DIY / In-House: Guesswork or omitted entirely
• Retroactive Study: Manual spreadsheets
• Exactera AI: Automated with audit trail

4. Process of experimentation

• DIY / In-House: No awareness of requirement
• Retroactive Study: Failed in 3 of 7 George trials
• Exactera AI: Structured hypothesis to result capture

5. Officer attestation support

• DIY / In-House: Officer signs blindly
• Retroactive Study: Sign based on consultant summary
• Exactera AI: Full dashboard visibility

6. Base-year substantiation

• DIY / In-House: No historical data kept
• Retroactive Study: Often missing; cost GOMI 8% of credit rate
• Exactera AI: Maintained automatically

The Bottom Line: Why Contemporaneous R&D Documentation Is Non-Negotiable

The George case isn’t ancient history — it was filed February 3, 2026. It proves that retroactive R&D studies produce documentation that crumbles under IRS scrutiny. Three trials disallowed. Credit rate cut in half. Millions in credits lost.

Every one of those failures traces back to the same root cause: documentation was reconstructed from memory instead of captured in real time.

Exactera’s AI platform doesn’t reconstruct the past. It documents the present. And that’s the difference between credits that survive an audit and credits that don’t.

Based on George v. Commissioner of Internal Revenue — T.C. Memo. 2026-10 
This material is for informational purposes only and does not constitute legal or tax advice

George v. Commissioner is a warning – but it is also a blueprint for what audit-ready R&D tax credit documentation looks like. Exactera’s real-time AI platform captures contemporaneous, project-level evidence automatically, so your credits are defensible from day one, not reconstructed after the fact. Speak to an R&D Tax Credit Specialist →